IABP Support Linked to Higher Vancomycin Troughs After Combined CABG and Valve Surgery

This single-center GEE analysis identifies dosing regimen, renal indices, and organ-support devices as independent correlates of vancomycin trough exposure in a cardiac surgical ICU population, with IABP as a hypothesis-generating signal.

📅 Journal publication: 2026 (online Oct 12, 2026) · Last updated: Oct 27, 2026

vancomycinglycopeptide antibiotictherapeutic drug monitoringtrough concentrationintra-aortic balloon pumpCRRTcardiac surgeryCABGvalve surgerygeneralized estimating equationsretrospective observational studypharmacokinetics Pharmacokinetics / TDM

Also in Cardiology, Infectious Disease / Antimicrobials

Background Information

Exploring new factors influencing vancomycin levels after complex heart surgeries.

Achieving optimal vancomycin trough concentrations post-surgery is complex, with intra-aortic balloon pump (IABP) support emerging as a potential factor. Factors such as dosing regimen, patient age, and IABP use are linked to higher vancomycin steady-state trough concentrations among patients undergoing CABG and valve surgery. These findings highlight the importance of integrating hemodynamic support and lab indices into individualized vancomycin dosing, beyond merely renal function adjustments. Consider hemodynamic support measures to guide vancomycin adjustments in cardiac surgery patients.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.

Subscribe for $8/month → Read this one free →

Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Shao BB, Feng T, Jiang JC, Xing WL, Ni M, Li LL, Liu C, Meng SP, Ma YC, Wang AF

Citation: Shao BB, Feng T, Jiang JC, et al. Independent correlates of vancomycin steady-state trough concentration among patients undergoing combined CABG and valve surgery: observational findings for intra-aortic balloon pump support. Frontiers in pharmacology. 2026;17:1888382. doi:10.3389/fphar.2026.1888382

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Founding member rate

$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →

Free account, no credit card. Includes 1 full deep analysis every month.

Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.